Draft:Medigen, Inc. (Frederick, Maryland, USA)

Medigen, Inc. is an independent U.S. biopharmaceutical company focused on the development and manufacturing of vaccines and therapies for emerging viruses.[1]. Company is located in Frederick, Maryland. Experimental vaccines developed by Medigen include vaccines for pandemic influenza viruses, alphaviruses, and flaviviruses[2]. Company has also manufactured vaccines for other independent vaccine developers, including experimental vaccines against COVID-19 and herpesviruses. Several pioneering vaccine technologies have been invented and patented in the U.S. and worldwide by Medigen scientists including virus-like particle vaccines, iDNA vaccines, and self-replicating RNA vaccines[3]

References

edit
  1. ^ https://medigen-usa.com/
  2. ^ Pushko, Peter; Lukashevich, Igor S.; Johnson, Dylan M.; Tretyakova, Irina (2024). "Single-Dose Immunogenic DNA Vaccines Coding for Live-Attenuated Alpha- and Flaviviruses". Viruses. 16 (3): 428. doi:10.3390/v16030428. PMC 10974764. PMID 38543793.
  3. ^ "DNA vaccines coding for live viruses could soon be tested in people".